Coherus BioSciences

$0.00 (0.00%) As of 1:01 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CHRS and other ETFs, options, and stocks.

About CHRS

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and Coherus COMPLETE.

CEO
Denny M. Lanfear
Employees
332
Headquarters
Redwood City, California
Founded
2010

CHRS Key Statistics

Market cap
606.22M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.19M
High today
$7.86
Low today
$7.17
Open price
$7.21
Volume
826.33K
52 Week high
$19.32
52 Week low
$5.60

CHRS Earnings

-$1.00
-$0.59
-$0.18
$0.23
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure